Articles From: Carbonite, Inc. 2014 Third Quarter Financial Results Now Available on Company's Website to Transgenomic and University of Melbourne Collaborate to Further Validate Ability of Multiplexed ICE COLD-PCRTM to Enable Personalized Cancer Treatment


JAIPUR and CHENNAI, India , Oct.
Sign-up for SunEdison Wins 150 Megawatts Of Solar Photovoltaic Projects In Karnataka India investment picks
http://media.marketwire.com/attachments/200910/443577_walterenergy.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1154741&ProfileId=051205&sourceType=1 BIRMINGHAM, AL --
Sign-up for Walter Energy Announces Third Quarter 2014 Results investment picks
Completed legacy ResCap system migration Recorded $100 million charge for potential settlement with New York regulator Surpassed 500,000 loan modifications milestone ATLANTA, Oct.
Sign-up for Ocwen Financial Announces Operating Results for Third Quarter 2014 investment picks
Reaffirms 2014 Earnings Outlook Adjusted 2014 Third Quarter EPS of $0.75 Revenue decreases 2.7% in the Third Quarter Same Store Sales - on a product only basis - decrease 6.9% in the Third Quarter PITTSBURGH , Oct.
Sign-up for GNC Holdings, Inc. Reports Third Quarter 2014 Results investment picks
MakerBot is excited to announce its partnership with Dell Financial Services (DFS) to offer 12 Months Special Financing on MakerBot® Replicator® 3D Printers when using Dell Preferred Account.* This offer is available on dell.com now through the holiday season.
Sign-up for MakerBot and Dell Financial Services™ Team Up Just in Time For The Holidays. investment picks
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Reports Third Quarter 2014 Results investment picks
http://media.marketwire.com/attachments/201406/76359_htgmolecular.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1155037&ProfileId=051205&sourceType=1 TUCSON, AZ --
Sign-up for HTG Announces Completion of IVD Development and Supply Agreement With Illumina investment picks
KCG reported a GAAP net loss of $9.6 million; pre-tax loss from continuing operations of $15.2 million includes a net benefit of $4.3 million unrelated to core operations KCG repurchased 3.6 million shares for approximately $42.1 million during the quarter JERSEY CITY, N.J. , Oct.
Sign-up for KCG Announces Third Quarter 2014 Results investment picks
NEW YORK , Oct.
Sign-up for Avon Declares Regular Quarterly Dividend investment picks
20% Growth Results in Record U.S. Feraheme Sales Lumara Health Acquisition on Track to Close in Fourth Quarter WALTHAM, Mass., Oct.
Sign-up for AMAG Pharmaceuticals Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2014 investment picks
AstraZeneca (NYSE:AZN) today announced that the U.S. Food and Drug Administration has approved once-daily XIGDUO™ XR (dapagliflozin and metformin hydrochloride extended-release) for the treatment of adults with type 2 diabetes.
Sign-up for U.S. FDA Approves Once-Daily XIGDUO™ XR Tablets for Adults with Type 2 Diabetes investment picks
STAMFORD, Conn., Oct.
Sign-up for Loxo Oncology to Present Pre-Clinical Data on LOXO-101 at Upcoming EORTC-NCI-AACR Symposium investment picks
Radian Group Inc. (NYSE: RDN) today reported net income for the quarter ended September 30, 2014, of $153.6 million, or $0.67 per diluted share.
Sign-up for Radian Reports Third Quarter 2014 Financial Results investment picks
NEW YORK, Oct.
Sign-up for Liquid Holdings Group Reports Third Quarter 2014 Results investment picks
- Non-GAAP(1) operating earnings increased 6 percent to $566 million - Non-GAAP diluted earnings per share (EPS) from continuing operations decreased 9 percent to $1.00 - Prior year first quarter included an $0.18 benefit related to tax settlements; excluding this impact, non-GAAP diluted EPS increased 9 percent DUBLIN, Ohio , Oct.
Sign-up for Cardinal Health Reports Fiscal 2015 First-Quarter Results investment picks
ConocoPhillips (NYSE:COP) today reported third-quarter 2014 earnings of $2.7 billion, or $2.17 per share, compared with third-quarter 2013 earnings of $2.5 billion, or $2.00 per share.
Sign-up for ConocoPhillips Reports Third-Quarter 2014 Results; Delivering Production and Margin Growth investment picks
Revenues increase 10%; Adjusted FFO per share increases 23% Midpoint of Normalized FFO guidance range increased $0.01 per share WASHINGTON , Oct.
Sign-up for DuPont Fabros Technology, Inc. Reports Third Quarter 2014 Results investment picks
PBS KIDS and Whole Foods Market (NASDAQ: WFM) announced a partnership today that will bring PBS KIDS’ line of educational and earth-friendly toys exclusively to the supermarket’s customers this holiday season.
Sign-up for PBS KIDS® and Whole Foods Market® Partner to Roll out Assortment of Sustainable Toys in Time for Holiday Season investment picks
Renaissance Gold Inc. (TSX: REN) (“RenGold” or the “Company”) is pleased to announce the execution of a six year extension of the large Pequop and Woodhills land package in Northeastern Nevada with New Nevada Resources, LLC ("NNR"). This includes 34,408 acres (13,924 Hectares) of important exploration terrain in the evolving Pequop Gold District.
Sign-up for Large Land Package in the Pequops is Given Six Year Extension investment picks
LEXINGTON, Ky., Oct.
Sign-up for Rhino Resource Partners LP Announces Third Quarter 2014 Financial and Operating Results investment picks
GUELPH, Ontario , Oct.
Sign-up for Canadian Solar Supplies Modules to Major Project in Nicaragua investment picks
Northern Trust has been named Best Private Bank in the USA for the sixth consecutive year by Professional Wealth Management ( PWM) and The Banker magazines, both published by The Financial Times Group.
Sign-up for Northern Trust Named “Best Private Bank in the USA” investment picks
Transgenomic, Inc. (NASDAQ:TBIO) , a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced a research agreement with the University of Melbourne to conduct additional clinical validation studies of its Multiplexed ICE COLD-PCR TM (MX-ICP) technology.
Sign-up for Transgenomic and University of Melbourne Collaborate to Further Validate Ability of Multiplexed ICE COLD-PCRTM to Enable Personalized Cancer Treatment investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Carbonite, Inc. 2014 Third Quarter Financial Results Now Available on Company's Website to Transgenomic and University of Melbourne Collaborate to Further Validate Ability of Multiplexed ICE COLD-PCRTM to Enable Personalized Cancer Treatment
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent